MSD Italia S.r.l.
MSD Italia is a leading biopharmaceutical company dedicated to inventing innovative products and solutions to improve and save lives. With over 65 years of presence in Italy and 130 years worldwide, MSD Italia focuses on research, development, and manufacturing of medicines, vaccines, and healthcare solutions. The company emphasizes responsibility, innovation, and collaboration with institutions and communities to address global health challenges and promote health equity. MSD Italia actively promotes diversity, equity, and inclusion, with 59% of its employees being women, and 63% of new hires and promotions also being women. Recognized as a Great Place To Work® and a Best Workplace™ for Women, MSD Italia fosters a positive, inclusive, and innovative work environment.
Industries
Nr. of Employees
large (251-1000)
MSD Italia S.r.l.
Patents
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
US-9573939-B2
View DetailsHeterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
US-9549917-B2
View DetailsTetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
US-9265773-B2
View Details
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
US-9573939-B2
View DetailsHeterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
US-9549917-B2
View DetailsTetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
US-9265773-B2
View DetailsProducts
Prophylactic vaccines (conjugate and polysaccharide platforms)
Development and commercialisation of prophylactic vaccines for pediatric and adult use using conjugate and polysaccharide platforms, including pediatric trial programs and post‑marketing effectiveness assessment.
Live‑attenuated or viral vector vaccine candidates for outbreak response
Vaccine candidates intended for rapid deployment in outbreak scenarios, including support for stockpiling and emergency immunization strategies.
Oral antiviral therapeutics
Orally administered antiviral small molecules developed for outpatient treatment of viral respiratory infections, supported by large‑scale supply and distribution mechanisms.
Monoclonal antibody immunotherapies
Monoclonal antibody therapies developed for oncology and other indications, with associated clinical development programs and real‑world evidence collection.
Digital health platforms and mobile applications for education and monitoring
Web portals and mobile applications for disease information, symptom monitoring and patient self‑management, including symptom‑tracking features and curated educational content.
Mobile app for cough frequency monitoring
A mobile application that counts daily cough events to support self‑monitoring and provide structured data to clinicians for assessment of chronic cough.
Prophylactic vaccines (conjugate and polysaccharide platforms)
Development and commercialisation of prophylactic vaccines for pediatric and adult use using conjugate and polysaccharide platforms, including pediatric trial programs and post‑marketing effectiveness assessment.
Live‑attenuated or viral vector vaccine candidates for outbreak response
Vaccine candidates intended for rapid deployment in outbreak scenarios, including support for stockpiling and emergency immunization strategies.
Oral antiviral therapeutics
Orally administered antiviral small molecules developed for outpatient treatment of viral respiratory infections, supported by large‑scale supply and distribution mechanisms.
Monoclonal antibody immunotherapies
Monoclonal antibody therapies developed for oncology and other indications, with associated clinical development programs and real‑world evidence collection.
Digital health platforms and mobile applications for education and monitoring
Web portals and mobile applications for disease information, symptom monitoring and patient self‑management, including symptom‑tracking features and curated educational content.
Mobile app for cough frequency monitoring
A mobile application that counts daily cough events to support self‑monitoring and provide structured data to clinicians for assessment of chronic cough.
Services
Telephone, email and online medical information services for healthcare professionals and customers; centralized scientific support and pharmacovigilance contact channels.
Collaborative manufacturing partnerships with contract development and manufacturing organizations to produce biotechnological products and support technology transfer and local production scale‑up.
Management of supply agreements, voluntary licensing arrangements and distribution partnerships with multilateral agencies to expand access in low‑ and middle‑income countries.
Design and delivery of disease awareness campaigns, multimedia content, podcasts and web portals to support prevention, patient education and clinician–patient communication.
At‑risk manufacturing scale‑up planning and coordination to produce large volumes of therapeutic cycles in response to public health emergencies, including coordination with supply and procurement partners.
Development and delivery of health literacy training, patient empowerment activities and collaborative projects with patient associations and academic partners to improve patient involvement in care and research.
Telephone, email and online medical information services for healthcare professionals and customers; centralized scientific support and pharmacovigilance contact channels.
Collaborative manufacturing partnerships with contract development and manufacturing organizations to produce biotechnological products and support technology transfer and local production scale‑up.
Management of supply agreements, voluntary licensing arrangements and distribution partnerships with multilateral agencies to expand access in low‑ and middle‑income countries.
Design and delivery of disease awareness campaigns, multimedia content, podcasts and web portals to support prevention, patient education and clinician–patient communication.
At‑risk manufacturing scale‑up planning and coordination to produce large volumes of therapeutic cycles in response to public health emergencies, including coordination with supply and procurement partners.
Development and delivery of health literacy training, patient empowerment activities and collaborative projects with patient associations and academic partners to improve patient involvement in care and research.
Expertise Areas
- Clinical trial management and pediatric vaccine trials
- Vaccine discovery and development (conjugate and polysaccharide platforms)
- Oncology research and immunotherapy development
- Infectious disease therapeutics and antiviral development
Key Technologies
- Conjugate and polysaccharide vaccine platforms
- Monoclonal antibody therapeutics and immuno‑oncology modalities
- Oral small‑molecule antiviral development
- Bioprocessing and GMP scale‑up for biologics and small molecules
News & Updates
MSD Italia has been recognized for its excellence in media communication, reflecting its effective corporate communication strategies.
The company has launched various initiatives including CrowdCaring, supporting refugees, and environmental projects.
MSD Italia has announced a strategic partnership and investment to enhance local manufacturing and innovation.
MSD Italia contributed with donations, support for healthcare workers, and development of COVID-19 treatments.
MSD's pneumococcal vaccine received a prestigious award for its real-world effectiveness in preventing pneumococcal diseases.
The company promotes immunization and health education through campaigns like World Immunization Week and HPV awareness.
MSD Italia has been recognized for its excellence in media communication, reflecting its effective corporate communication strategies.
The company has launched various initiatives including CrowdCaring, supporting refugees, and environmental projects.
MSD Italia has announced a strategic partnership and investment to enhance local manufacturing and innovation.
MSD Italia contributed with donations, support for healthcare workers, and development of COVID-19 treatments.
MSD's pneumococcal vaccine received a prestigious award for its real-world effectiveness in preventing pneumococcal diseases.
The company promotes immunization and health education through campaigns like World Immunization Week and HPV awareness.